• Welcome to the Crispy Money forums, a community of people who share their experience with investing, saving money, earning tips, avoiding scams and living life to it's fullest.
    To start posting in our forums, and comment on articles and blogs please register free by clicking here.

Lower Cost Alternatives To The EpiPen

  • Author Author Ken Payne
  • Create date Create date
  • Blog entry read time Blog entry read time 1 min read
Pharmaceutical company Mylan has taken a great deal of heat this year for an over 400% price increase in the price of their EpiPen product. This potentially life-saving medication for allergic reactions sells for $600+ in the USA. Mylan's CEO has defended the price increases due to spending for "creating access and awareness, and improving the product."

bee-24638_640.jpgShe further went on to say they make "only" $100 off of every two-pack of autoinjectors. Frankly, this isn't believable considering they sell an identical generic version for about $300. Furthermore, they sell EpiPen in the U.K. for $69, $100 in France and $200 in Germany. In 2007, prior to Mylan acquiring the product, EpiPen sold for $57.

I'm all for free markets, but clearly, something is awry here. But thanks to that same free market, and the profit potentials their price increases give to would-be competitors, there are now other less expensive alters available.

Adrenaclick, a generic alternative to EpiPen, runs about $140 to $200 for a single pack, or about $300 for a two-pack. CVS pharmacy has also introduced a store brand version of Adrenaclick for $109.99 for a two-pack, bringing the cost down to $55 each.

When buying either of these, make sure your doctor prescribes for Adrenaclick, or according to CVS write it for "epinephrine auto-injector".

Image: CC0 Public Domain, Free for commercial use, No attribution required https://pixabay.com/en/bee-honey-wasp-hornet-funny-cute-24638/


There are no comments to display.

Blog entry information

Ken Payne
Read time
1 min read
Last update

More entries in Misc

More entries from Ken Payne